REG - Cambridge Nutrition. - Notice of AGM & Annual Report

Cambridge Nutritional SciencesAnnouncement

28/08/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250828:nRSb9111Wa&default-theme=true

RNS Number : 9111W  Cambridge Nutritional Sciences PLC  28 August 2025

Cambridge Nutritional Sciences plc

(the 'Company' or 'CNS')

 
Notice of AGM and Annual Report to 31 March 2025

 

CNSL (AIM: CNSL), the specialist medical diagnostics company focused on
delivering a personalised approach to nutrition for better health, confirms
that the Notice of Annual General Meeting ('AGM') has been finalised along
with the Annual Report and Accounts for the year ended 31 March 2025. The
Company's AGM will be held on Thursday 25 September 2025 at 3.00pm at E-space
North, 181 Wisbech, Littleport, Ely, CB6 1RA.

The Annual Report will be posted to shareholders next week and will shortly be
made available on the Company's website at:

https://www.cnsplc.com/financials/ (https://www.cnsplc.com/financials/)

 

Contacts:

 Cambridge Nutritional Sciences PLC                www.cnsplc.com (http://www.cnsplc.com/)
 James Cooper, Chief Executive Officer             investors@cnsplc.com (mailto:investors@cnsplc.com)

 Ajay Patel, Chief Financial Officer

 Cavendish Capital Markets Limited                 Tel: 020 7220 0500
 Geoff Nash / Edward Whiley / (Corporate Finance)
 Nigel Birks / Harriet Ward (Sales and ECM)

 

About Cambridge Nutritional Sciences plc

Cambridge Nutritional Sciences plc (AIM: CNSL) is the specialist medical
diagnostics company focused on delivering a personalised approach to nutrition
for better health.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NOAEAAPXALSSEFA